Regencell Bioscience Holdings Limited (RGC) total debt
Regencell Bioscience Holdings Limited (RGC) carried total debt of $295.81K at the end of fiscal 2026 (June 30, 2026). Figures as of 18 Nov 2026, 10:34 UTC, from the company's filings with the SEC and Yahoo Finance.
Key facts
- Total debt, fiscal 2026
- $295.81K
- Highest on record
- $771.26Kfiscal 2022
- Lowest on record
- $85.74Kfiscal 2024
- Fiscal years on record
- 42022–2026
Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.
Regencell Bioscience Holdings Limited total debt, in more detail
Across the 4 fiscal years on record (2022–2026), the highest was $771.26K in fiscal 2022 and the lowest $85.74K in fiscal 2024.
Total debt was 0.0× shareholders' equity at the end of fiscal 2026.
Total debt by fiscal year
Regencell Bioscience Holdings Limited total debt, year by year
| Fiscal year | Total debt | Change | Year ended | Debt ÷ equity |
|---|---|---|---|---|
| 2026 | $295.81K | — | 0.0× | |
| 2024 | $85.74K | 81.5% down | 0.0× | |
| 2023 | $463.67K | 39.9% down | 0.0× | |
| 2022 | $771.26K | — | 0.0× |
Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.
How it is calculated
Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative.
How to read it
Debt magnifies results in both directions — set it against cash, equity and the profit available to pay the interest rather than reading it alone.
Regencell Bioscience Holdings Limited, figure by figure
- Regencell Bioscience Holdings Limited market cap
- Regencell Bioscience Holdings Limited revenue
- Regencell Bioscience Holdings Limited earnings
- Regencell Bioscience Holdings Limited earnings per share (EPS)
- Regencell Bioscience Holdings Limited P/E ratio
- Regencell Bioscience Holdings Limited P/S ratio
- Regencell Bioscience Holdings Limited P/B ratio
- Regencell Bioscience Holdings Limited free cash flow
- Regencell Bioscience Holdings Limited operating margin
- Regencell Bioscience Holdings Limited dividend
- Regencell Bioscience Holdings Limited shares outstanding
- Regencell Bioscience Holdings Limited cash on hand
- Regencell Bioscience Holdings Limited total assets
- Regencell Bioscience Holdings Limited return on equity (ROE)
- Regencell Bioscience Holdings Limited return on invested capital (ROIC)
Regencell Bioscience Holdings Limited (RGC) overview: price, valuation and scorecard
Regencell Bioscience Holdings Limited total debt: questions and answers
How much debt does Regencell Bioscience Holdings Limited have?
Regencell Bioscience Holdings Limited (RGC) carried total debt of $295.81K at the end of fiscal 2026 (June 30, 2026).
What are the highest and lowest total debt figures on record for Regencell Bioscience Holdings Limited?
Across the 4 fiscal years on record (2022–2026), the highest was $771.26K in fiscal 2022 and the lowest $85.74K in fiscal 2024.
How does Regencell Bioscience Holdings Limited's debt compare with its equity?
Total debt was 0.0× shareholders' equity at the end of fiscal 2026.
How is Regencell Bioscience Holdings Limited's total debt calculated?
Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative. For Regencell Bioscience Holdings Limited it is on record here for 4 fiscal years, 2022 to 2026.
Fiscal years are named for the calendar year they end in.
Learn: total debt
All stocks guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- Analyst price targets and ratings: what they mean
An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.
Cite this page
Funkfolio, “Regencell Bioscience Holdings Limited (RGC) total debt”, data as of 18 November 2026. https://funkfolio.com/stock/RGC/total-debt
Underlying data: the company's filings with the SEC and Yahoo Finance.